The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Programmed cell death protein 1 (PD-1) and its ligand (PD-L1) are key regulators of immune responses.
• PD-1/PD-L1 interactions are implicated in anti-tumor immunity and normal germinal center (GC) reactions.
• T follicular helper (T_FH), regulatory T (T_FR), and regulatory B (Breg) cells play roles in GC B cell selection and the lymphoma microenvironment.

Purpose of the Study:

• To elucidate the role of PD-1/PD-L1 interactions in the tumor evolution of diffuse large B cell lymphoma (DLBCL).
• To propose a two-phase model for DLBCL progression involving PD-1/PD-L1 signaling and immune evasion.

Main Methods:

• Discussion of a proposed two-phase progression model for DLBCL.
• Analysis of PD-1/PD-L1 interactions in the context of GC-derived lymphomagenesis.
• Integration of molecular and cellular mechanisms driving DLBCL survival and proliferation.

Main Results:

• Malignant B cells utilize PD-1/PD-L1 crosstalk for survival and tumor expansion via positive selection signals.
• DLBCL cells acquire higher PD-L1 expression and IL-10 secretion, exhibiting Breg-like features.
• A complex immunosuppressive microenvironment is established, impairing T_FR regulation and T_FH anti-tumor functions while promoting immune evasion from CD8+ T cells.

Conclusions:

• PD-1/PD-L1 signaling is integral to DLBCL tumor evolution and immune evasion.
• Understanding these interactions provides a framework for novel PD-1/PD-L1-based combination immunotherapies for DLBCL.
• The study highlights the critical role of the tumor microenvironment in DLBCL pathogenesis.